Orbital Therapeutics has filed a notice of an exempt offering of securities to raise $270,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Orbital Therapeutics is raising $270,000,000.00 in new funding. Sources indicate that as part of senior management Chairman, John Maraganore played a key role in securing…